| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
ARTICLES |
Department of Physiology, Biomedical Center, Uppsala University (M.S., E.J.), Uppsala S-75123, Sweden; the Department of Physiology, University of Odense (O.S.), Odense DK-5000, Denmark; and the Department of Neuroscience, University of Pittsburgh (W.H., E.M.S., A.F.S.), Pittsburgh, Pennsylvania 15260 U.S.A.
Address all correspondence and requests for reprints to: Dr. Mats Sjöquist, Department of Physiology, Box 572, Biomedical Center, S-75123 Uppsala, Sweden. E-mail: mats.sjoquist{at}physiology.uu.se
| Abstract |
|---|
|
|
|---|
| Introduction |
|---|
|
|
|---|
One difference between the increase in circulating OT levels that occurs in these various conditions is that pituitary OT secretion during lactation and parturition is intermittent rather than continuous (11, 12). Furthermore, the increased firing rate of hypothalamic oxytocinergic neurons during lactation and parturition also occurs in a pulsatile fashion, with an interval of 515 min between pulses of neuronal activity and OT release (7, 8, 9, 10, 13). This pattern of OT release results in acute increases in plasma OT levels that rapidly return to baseline before the subsequent pulse (9). Thus, it is plausible that natriuresis does not occur during lactation and parturition because the increase in plasma OT levels is pulsatile rather than steady.
The present studies were designed to test the hypothesis that natriuresis is not caused by pulsatile increases in plasma OT levels, produced experimentally to simulate the profile of plasma OT levels that occurs with lactation. The plasma renin concentration (PRC) was also measured in these studies because OT receptors in kidneys are present in the macula densa (14, 15, 16, 17, 18), which plays an important role in the stimulation of renin secretion (19).
| Materials and Methods |
|---|
|
|
|---|
On the day of the experiment, rats were anesthetized with Inactin (120 mg/kg, ip; Research Biochemicals International, Natick, MA) and placed on a servo-controlled heating pad to maintain rectal temperatures at 37.5 C. After tracheotomy, a femoral vein was cannulated for continuous infusion (5 ml/kg·h) of Ringers solution (129 mM NaCl, 2.5 mM KCl, 25 mM NaHCO3, and 0.75 mM CaCl2) to compensate for fluid losses during the experiment and for other iv treatments according to the protocols. A femoral artery was cannulated for blood sampling and monitoring arterial blood pressure. The urinary bladder was cannulated through a small abdominal incision for collection of urine samples. Experiments began 45 min after completion of the operative procedures.
Experimental protocols
Because the critical studies testing the hypothesis used
Inactin-anesthetized rats, Exp 1 was performed to determine whether OT
is a potent natriuretic hormone in this preparation, as it is in
conscious rats (1, 2). After a 60-min control period during which all
rats were infused with Ringers solution at the rate of 5 ml/kg·h,
rats received for 80 min an iv infusion of OT at different rates: 0
(Ringers solution), 8, 25, 80, 250, 800, or 2500 ng/kg·h. Urine was
collected in seven successive 20-min periods during the 140-min
experimental period, for measurement of volume, Na+,
K+, and osmolality. Blood samples were taken at the end of
the period for measurement of plasma OT by RIA.
Exp 2 examined the effects of OT, administered iv in a continuous infusion or in pulsatile injections, on urinary Na+ excretion and renin secretion. Urine was collected during six successive periods of 20 min. After two control periods, OT was administered for 80 min in a dose of 125 ng/kg·h either as a continuous infusion or as 50-µl bolus injections at 1-, 5-, or 10-min intervals. A Y connector tube for injections was placed close to the insertion point of the venous catheter, so that the bolus injections of OT could occur simultaneously to the continuous infusion of vehicle. The total amounts of OT and administered volumes were calculated to be the same in all groups. A vehicle-treated group received only the Ringers solution.
At the end of experiments involving continuous infusion of OT, vehicle treatment, or bolus injection of OT at 10-min intervals, 23 ml blood were collected from the arterial line into ice-cold tubes containing 5% 0.1 M Na2 EDTA and centrifuged at 4 C and 1100 x g for 15 min. Plasma was withdrawn and stored at -70 C pending analysis of OT or PRC.
Analyses
In urine samples, the Na+ and K+
concentrations were assayed by flame photometry (IL 543,
Instrumentation Laboratory, Milan, Italy), and osmolality was measured
by freezing point depression (model 3MO, Advanced Instruments, Needham,
MA).
OT was measured by RIA (20). Antiserum RI3 (Division of Neurophysiology and Neuropharmacology, Medical Research Council, London, UK), diluted 1:40,000, was used in the assay; the cross-reactivity of RI3 with vasopressin was 0.012%. All OT values included in this report were generated in a single assay; the assay sensitivity was 5 pg/ml, and the intraassay coefficient of variation was 8.4%. Recovery of OT from exogenously enriched plasma was 80.5%, and values were not corrected for this recovery.
PRC was measured by RIA of generated angiotensin I (21). Briefly,
aliquots of plasma were diluted 20, 40, and 80 times with
Tris(hydroxymethyl)aminomethane (Tris) buffer containing human albumin,
and 5-µl portions of these samples were incubated for 24 h at 37
C with 20 µl of a reaction mixture that contained purified rat renin
substrate (
1200 ng angiotensin I equivalents/ml). This incubation
was followed by RIA of generated angiotensin I. Renin is expressed in
Goldblatt units compared with renin standards (65/119) from the
National Institute for Biological Standards and Control (Potters Bar,
UK; 1 µGU = 160 pg angiotensin I/ml·h).
Statistical analysis
Results are presented as the mean ± SEM.
Comparisons of groups were made by two-way ANOVA with repeated measures
in the time parameter. Comparisons of OT levels and PRC between groups
during the two last periods were made using Tukeys highest
significant difference test. P < 0.05 was
considered statistically significant.
| Results |
|---|
|
|
|---|
|
|
|
|
|
| Discussion |
|---|
|
|
|---|
The pattern of OT release during suckling has been well characterized in rats. Oxytocinergic neurons in paraventricular and supraoptic nuclei of the hypothalamus increase their firing rates for 24 sec at regular intervals of 515 min during suckling; each period of neurosecretory activity results in the release of about 13 ng OT from the posterior pituitary into the circulation. Blood samples collected within 30 sec of a suckling-induced burst of neurosecretory activity showed increases in plasma OT levels to 60100 pg/ml, which declined quickly and had returned to control levels within 5 min (8, 9, 10). This time course of changes in plasma OT levels agrees well with that occurring after iv bolus injections of OT with 5- or 10-min intervals between injections (10). Nonetheless, this paradigm of OT administration does not result in natriuresis, which was observed during more continuous administration of the same amount of OT. Therefore, it appears that the OT receptors in mammary glands (and uterus) are sensitive to pulsatile exposure to OT, whereas the OT receptors mediating natriuresis require more continuous exposure to OT.
It is also possible that changes in OT receptor responsiveness during lactation or parturition may contribute to the lack of OT-induced natriuresis under these conditions. Estrogen treatment leads to an increase in renal OT receptor messenger RNA, as is also the case in the uterus and pituitary. However, at term the renal OT receptor messenger RNA decreased, whereas the levels in the uterus and pituitary increased (14, 22). Estrogen treatment increased the natriuretic effect of OT in ovariectomized rats (23). As male rats were the subjects in the current experiments, the effect of the pulsatile pattern on the renal actions of OT could not be accompanied by an influence of the female steroid hormones.
The dose-related natriuretic response to increases in plasma OT levels in Inactin-anesthetized rats was quantitatively similar to that observed in conscious rats (1, 2). In both Inactin-anesthetized rats and conscious male rats, the basal plasma OT concentration was approximately 10 pg/ml and increased to approximately 20 pg/ml under moderate hypernatremic conditions (3, 4). The apparent threshold for natriuresis of 1526 pg/ml was much higher than was reported in a previous study (2), in part because rats in the earlier study (but not the present one) had been maintained on a low sodium diet to reduce basal urinary Na+ excretion and thereby make it easier to detect small increases in Na+ loss. Although in that study the suprathreshold effects of OT on urinary Na+ loss were linear, plasma OT levels achieved by iv infusion of OT did not exceed 7090 pg/ml. A much larger range of doses was administered in the present experiment, and the results clearly indicate that further increases in natriuresis are not produced by very high, supraphysiological doses of OT that produce plasma OT levels above approximately 100 pg/ml. Thus, there is an apparent ceiling in the natriuretic effects of OT in rats.
The present study also examined the effect of iv OT on renin secretion, as renal OT receptors are present in the macula densa. Infusion of OT in rats significantly increased PRC. PRA was reported to increase when OT was infused into the vertebral artery of anesthetized dogs (24), but systemic OT levels were not measured in that experiment. The OT infusion associated with elevated PRC in the present experiment would be expected to increase plasma OT levels to 60100 pg/ml based on the results of Exp 1. Because that level is similar to the response of rats to hypovolemia (25) and hypotension (26), it is possible that such changes in plasma OT levels contribute to the increase in PRC that is well known to occur when circulatory volume or pressure is reduced. Further experiments are needed to evaluate this hypothesis.
Interestingly, the increase in PRC observed in response to OT administration was similar regardless of whether OT was given by constant infusion or in a pulsatile fashion with 10-min intervals between injections. This observation stands in marked contrast to the different effects of those treatments on OT-induced natriuresis and suggests that OT-induced renin release is regulated independently of natriuresis. The increase in PRC associated with the pulsatile administration of OT suggests that increased PRC should be observed during lactation and parturition; in fact, PRC has been reported to increase in lactating rats (22).
In conclusion, OT administered iv to simulate the pulsatile pattern of pituitary OT release associated with lactation lacked the natriuretic action of continuously infused OT. Thus, the pulsatile pattern of OT release may protect against OT-induced loss of Na+ and fluid during suckling and parturition, which would be a sensible arrangement for rats under circumstances in which further fluid losses were best minimized. OT administration also increased PRC, regardless of whether OT was given by continuous infusion or in bolus injections. Thus, OT has multiple and independent effects on renal excretion and renin secretion, which have differing influences on Na+ and fluid homeostasis.
| Acknowledgments |
|---|
| Footnotes |
|---|
Received November 2, 1998.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
Z. K. Krowicki and D. R. Kapusta Tonic Nociceptinergic Inputs to Neurons in the Hypothalamic Paraventricular Nucleus Contribute to Sympathetic Vasomotor Tone and Water and Electrolyte Homeostasis in Conscious Rats J. Pharmacol. Exp. Ther., April 1, 2006; 317(1): 446 - 453. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Sabatier and G. Leng Presynaptic actions of endocannabinoids mediate {alpha}-MSH-induced inhibition of oxytocin cells Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2006; 290(3): R577 - R584. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Huang, M. Sjoquist, O. Skott, E. M. Stricker, and A. F. Sved Oxytocin antagonist disrupts hypotension-evoked renin secretion and other responses in conscious rats Am J Physiol Regulatory Integrative Comp Physiol, March 1, 2001; 280(3): R760 - R765. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Huang, M. Sjoquist, O. Skott, E. M. Stricker, and A. F. Sved Oxytocin-induced renin secretion in conscious rats Am J Physiol Regulatory Integrative Comp Physiol, January 1, 2000; 278(1): R226 - R230. [Abstract] [Full Text] [PDF] |
||||
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |